2% lignocaine (DrugBank: Lignocaine)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 84 | Sarcoidosis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01955824 (ClinicalTrials.gov) | May 2014 | 25/9/2013 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | A RCT ON CLINICAL EFFICACY OF 1% vs. 2% LIGNOCAINE IN COUGH SUPPRESSION AND PAIN RELIEF IN PATIENTS UNDERGOING FLEXIBLE BRONCHOSCOPY | Lung Cancer;Tuberculosis;Sarcoidosis;Interstitial Lung Disease | Drug: 1% lignocaine;Drug: 2% lignocaine | Postgraduate Institute of Medical Education and Research | NULL | Completed | 12 Years | 80 Years | Both | 500 | Phase 2;Phase 3 | India |